Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders, as well as innovative thinkers who are working to meet the challenges of the coronavirus pandemic.
In this installment, I check in with Richard Fabian, president and CEO of Fujifilm Sonosite, and Diku Mandavia, CMO for Fujifilm Sonosite, to discuss the company's FDA approval for using point-of-care ultrasound for COVID-19, the diagnostic value it brings to the pandemic, and what the road to regulatory approval looked like.
I initially spoke to Dr. Mandavia back in May
about the role of point-of-care ultrasound in the pandemic, and since then the technology has continued to prove advantageous.
We hope you enjoy the video. Please tell us what you think, and let us know who you would like to see interviewed next: